Science Explorer Back to mapMap
Discussion
Researcher · IPO Porto · Portugal

Júlio Oliveira

Júlio Oliveira publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-9576-3486 OpenAlex
World rank
#1,371,717
of 7,710,434 ranked researchers
Rank in Portugal
#5,589
of 41,760
Works
113
Citations
1.7k
Citations per work
15.3
h-index
23
i10-index 30Top 15% in Pulmonary and Respiratory Medicine
Júlio Oliveira

What does Júlio Oliveira research?

Júlio Oliveira's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 62 works · 54.5% of their workMedicine: 62 works · 54.5% of their workPulmonary and Respiratory Medicine: 27 works · 23.6% of their workOncology: 23 works · 20.2% of their workSurgery: 9 works · 7.7% of their workInfectious Diseases: 3 works · 3.0% of their workEverything else: 34 works · 30.0% of their workLife Sciences: 18 works · 15.5% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 15.5% of their workCancer Research: 10 works · 8.6% of their workMolecular Biology: 8 works · 6.9% of their workTHEIR WORKJúlio Oliveira113works
Life Sciences16%Health Sciences54%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6254.5%
  2. Everything else3430.0%
    1. Biochemistry, Genetics and Molecular Biology1815.5%
  1. 1Pulmonary and Respiratory Medicine24% of their works
  2. 2Oncology20% of their works
  3. 3Cancer Research9% of their works
  4. 4Surgery8% of their works
  5. 5Molecular Biology7% of their works
  6. 6Infectious Diseases3% of their works

Research topics

Which keywords describe Júlio Oliveira's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Cancer Genomics, Mutational Signatures and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy473 topics
  2. Clinical Trials292 topics
  3. Chemotherapy233 topics
  4. ALK Inhibitors201 topic
  5. EGFR Mutations201 topic
  6. Cancer Genomics181 topic
  7. Mutational Signatures181 topic
  8. Immune Checkpoint Blockade111 topic
  9. PD-1 and PD-L1111 topic
  10. Genomic Profiles91 topic
  11. Small-Cell Lung Cancer91 topic
  12. Cetuximab71 topic
  13. Endoscopic Resection71 topic
  14. Gastric Cancer71 topic
  15. KRAS Mutations71 topic
  16. DNA Methylation51 topic
  17. Histone Modification51 topic
  18. Coronavirus41 topic
  19. SARS-CoV-241 topic

Where does Júlio Oliveira work?

Júlio Oliveira's main affiliation in the publication record is IPO Porto, Portugal.

How many publications and citations does Júlio Oliveira have?

OpenAlex counts 113 works and 1,730 citations for Júlio Oliveira, an h-index of 23, ranking #1,371,717 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Júlio Oliveira. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.